DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
11.56
-0.04 (-0.34%)
Sep 25, 2026, 4:00 PM EDT - Market closed
DBV Technologies Market Cap
DBV Technologies has a market cap or net worth of $681.87 million as of September 25, 2026. Its market cap has increased by 165.94% in one year.
Market Cap
681.87M
Enterprise Value
515.09M
1-Year Change
165.94%
Ranking
Category
Stock Price
$11.56
ChartMarket Cap Chart
Since October 22, 2014, DBV Technologies's market cap has decreased from $844.80M to $681.87M, a decrease of -19.29%. That is a compound annual growth rate of -1.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 681.87M | 5.16% |
| Dec 31, 2025 | 648.40M | 987.92% |
| Dec 31, 2024 | 59.60M | -67.52% |
| Dec 29, 2023 | 183.50M | -36.22% |
| Dec 30, 2022 | 287.70M | 63.47% |
| Dec 31, 2021 | 176.00M | -28.57% |
| Dec 31, 2020 | 246.40M | -68.16% |
| Dec 31, 2019 | 773.80M | 141.13% |
| Dec 31, 2018 | 320.90M | -73.54% |
| Dec 29, 2017 | 1.21B | -28.69% |
| Dec 30, 2016 | 1.70B | 22.23% |
| Dec 31, 2015 | 1.39B | 39.07% |
| Dec 31, 2014 | 1.00B | 18.43% |
| Oct 22, 2014 | 844.80M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aclaris Therapeutics | 776.47M |
| Wave Life Sciences | 776.37M |
| Design Therapeutics | 768.50M |
| Olema Pharmaceuticals | 762.98M |
| Pharming Group | 758.99M |
| Annexon | 725.14M |
| Verastem | 717.26M |
| Nuvectis Pharma | 705.39M |